2021-09-14 08:00
Biovica, active in cancer diagnostics, today announces that DiviTumTKa results from the large BioItaLEE study will be presented as a poster during the European Society for Medical Oncology (ESMO) meeting 16 to 21 September 2021. The results strengthen...
2021-09-13 08:07
Biovica, active in cancer diagnostics, today announced that the company’s expected timeline for its updated 510(k)-application to the US Food and Drug Administration (FDA) has been prolonged due to delay in response from FDA. As Biovica is still...
2021-08-31 11:20
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 31 August 2021 and the following resolutions were passed by the meeting. ADOPTION OF THE INCOME STATEMENT AND BALANCE SHEET The annual...
2021-08-31 08:00
Significant events during the first quarter Significant events after the end of the period Audiocast: When: 2 September 2021 at 10:00 AM CET Where: https://tv.streamfabriken.com/biovica-international-q1-2021-2022 Phone numbers: SE: +46850558365, DK: +4578150108...
2021-08-27 14:30
Biovica, active in cancer diagnostics, today announced that a pre-recorded presentation with CEO Anders Rylander has been published. The Annual General Meeting of Biovica International AB on 31 August 2021 will take place without physical presence, due...
2021-08-10 08:00
Biovica, active in cancer diagnostics, today announced that Warren Cresswell has been appointed President Americas and will be part of the management team. Warren Cresswell has previously worked in senior management roles for 17 years at the Danish diagnostics...
2021-07-30 11:15
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the annual general meeting on Tuesday 31 August 2021. Information with respect to the coronavirus The Company is mindful of the health...
2021-06-30 08:00
Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website Financials – Biovica Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO...
2021-06-17 08:00
Preparations for the launch of DiviTum®TKa Significant events during the fourth quarter Significant events after the end of the period Audiocast: When: 18 June 2021 at 10.00 CET Where: https://tv.streamfabriken.com/biovica-international-q4-2020-2021...
2021-05-22 14:30
Biovica, active in cancer diagnostics, will host a virtual Capital Markets Day on Wednesday 9 June from 14.00 to 16.30. Biovica is approaching market launch of DiviTum®TKa in the US for the monitoring of metastatic breast cancer treatments. Today...
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects